What’s your approach to treatment of low to intermediate-low risk category precapillary PH in ESRD patients?

Community
Company
News
Contact Us
Sign in

Topics: Pulmonology • Pulmonary Vascular Disease

Certain medications like tadalafil are renally cleared and can accumulate in ESRD, while selexipag is not well studied in ESRD. Do you consider inhaled vs oral treprostinil?

Related Questions

What is your approach to management of elderly patients with cardiopulmonary comorbidities and severe pulmonary hypertension?

How do you approach management of a patient with idiopathic PAH and +ANA, but no other current symptoms/signs of active rheumatologic disease?

How would you manage a patient with morbid obesity who presents with new symptomatic pulmonary embolism a few days after he was started on DOAC for DVT?

Would you place an IVC filter in a patient with an acute intermediate risk PE and a proximal DVT who is on anticoagulation?

How do you risk stratify patients with different WHO groups of pulmonary hypertension prior to non-cardiac surgeries?

How long post operatively do you wait before transitioning from parenteral anticoagulation to oral anticoagulants after pulmonary thromboendarterectomy for CTEPH?

How do you determine if pulmonary hypertension is disproportionate to the severity of lung disease?

Do you obtain an echocardiogram as a part of risk stratification in all patients hospitalized with an acute pulmonary embolism?

How would you approach a pulmonary-renal PR3+ ANCA vasculitis patient who has persistent re-narrowing of mainstem bronchus after several dilatation and stenting procedures, with other anca features well-controlled on rituximab & avacopan?

Do you consider pulmonary hypertension related to sarcoidosis to be an indication to start steroids?